LetterAssociation between pediatric psoriasis and the metabolic syndrome
References (5)
- et al.
Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis
Am J Med
(2010) - et al.
The association of psoriasis and elevated blood lipids in overweight and obese children
J Pediatr
(2011)
Cited by (0)
This investigator-initiated project was funded by a grant from Amgen Inc.
Disclosure: Dr Gottlieb currently has consulting/advisory board agreements with the following: Abbott Laboratories, Actelion, Alnylam, Amgen, Beiersdorf Inc, Astellas Pharma US Inc, BIND Biosciences Inc, Canfite, Celgene Corp, Centocor Ortho Biotech Inc, Cytokine Pharmasciences, DermiPsor, Incyte Corp, Merck & Co Inc, Novo Nordisk A/S, Ono, Pfizer Inc, Pharmaceutical Product Development Inc, Puretech, Schering-Plough Corp, and UCB. Dr Gottlieb is the principal investigator for research/educational grants awarded to Tufts Medical Center from Abbott Laboratories, Amgen, Celgene, Centocor Ortho Biotech Inc, Immune Control, Novo Nordisk A/S, Pfizer Inc, and UCB. Dr Lizzul is an investigator with the following: Abbott Laboratories, Centocor Ortho Biotech Inc, Celgene Corp, Pfizer Inc, and Novartis Inc. The remaining authors have no conflicts of interest to declare.